New stem cell therapy could ease stiff spine disease
NCT ID NCT07534644
First seen Apr 17, 2026 · Last updated Apr 30, 2026 · Updated 2 times
Summary
This early-stage trial tests a new stem cell treatment (HS_SW01) for people with ankylosing spondylitis, a condition that causes spine inflammation and stiffness. The study will enroll 18 adults aged 18-65 to check if the treatment is safe and helps reduce symptoms. Participants receive an injection of stem cells from donated umbilical cords, and researchers will monitor side effects and measure improvement in spinal function over 12 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANKYLOSING SPONDYLITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.